Guidelines to inform the clinical application of the latest advances in genetics and human reproduction

Guidelines to inform the clinical application of the latest advances in genetics and human reproduction

Among many others already taking place in the world of genetics and human reproduction, advances such as the marketing of genetic testing, new massive genetic sequencing technologies and the development of techniques allowing for genome editing, are set to entail significant changes is the diagnosis and treatment of certain diseases and fertility problems.

For this reason, for a few years now, the two European societies bringing together the key experts in the field of Genetics and Assisted Human Reproduction (The European Society of Human Genetics (ESHG) and The European Society for Human Reproduction and Embryology (ESHRE) regularly meet with a view to assessing the impact that these steps forward will have in society.

A paper recently published in The European Journal of Human Genetics, with the participation of Dr. Anna Veiga, the R + D director of the Reproductive Medicine Unit of Dexeus Mujer, compiles a set of recommendations recognised by experts from both scientific societies to guide the application of the latest advances occurring in these areas in clinical practice.

Reference article:
Recent developments in genetics and medically assisted reproduction: from research to clinical applications
Harper JC, Aittomäki K, Borry P, Cornel MC, de Wert G, Dondorp W, Geraedts J, Gianaroli L, Ketterson K, Liebaers I, Lundin K, Mertes H, Morris M, Pennings G, Sermon K, Spits C, Soini S, van Montfoort APA, Veiga A, Vermeesch JR, Viville S, Macek M Jr; on behalf of the European Society of Human Reproduction and Embryology and European Society of Human Genetics.
Eur J Hum Genet. 2018 Jan;26(1):12-33. doi: 10.1038/s41431-017-0016-z. Epub 2017 Dec 4.


(+34) 93 227 48 96

oder füllen Sie dieses Formular aus und wir rufen Sie schnellstmöglich zurück

Ich will über die Dexeus Mujer Neuigkeiten informiert werden und ihre Newsletter bekommen:
Wenn Sie weitere Informationen benötigen, wenden Sie sich bitte an unsere Internationale Abteilung.